Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate
- PMID: 6386761
- DOI: 10.1016/0360-3016(84)90263-3
Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate
Abstract
The incidence, severity, time of onset, and clinical course of complications of treatment have been reviewed in the RTOG studies of extended field irradiation in carcinoma of the prostate. A total of 526 patients, entered between 1976 and 1980 and followed for a minimum of 18 months, comprised the study population. In most instances of treatment-related morbidity, the symptoms were recorded during the first several months to 1 year following completion of treatment. Late occurrences, however, were not uncommon in certain types of radiation-produced injuries, such as proctitis, hematuria, and urethral strictures. Resolution of symptoms has been observed in a large proportion of patients including those with late occurrences of treatment-related morbidity, although the probability and the pattern of resolution differed considerably from one type of morbidity to another. Symptoms of cystitis are more likely to abate than those of proctitis. In patients who develop symptoms of proctitis the probability of persistence of symptoms beyond the second year following occurrence has been estimated at 20%-30%. Hematuria and symptoms secondary to urethral strictures seem to be even more likely to recur or persist, while genital and leg edema remain chronic in the majority of patients.
Similar articles
-
Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate--analysis of RTOG study 75-06.Int J Radiat Oncol Biol Phys. 1987 Mar;13(3):351-7. doi: 10.1016/0360-3016(87)90008-3. Int J Radiat Oncol Biol Phys. 1987. PMID: 3494005 Clinical Trial.
-
Complications of definitive radiotherapy for carcinoma of the prostate.Int J Radiat Oncol Biol Phys. 1981 Oct;7(10):1341-8. doi: 10.1016/0360-3016(81)90029-8. Int J Radiat Oncol Biol Phys. 1981. PMID: 7319859 No abstract available.
-
Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate.Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):811-9. doi: 10.1016/0360-3016(94)90100-7. Int J Radiat Oncol Biol Phys. 1994. PMID: 8138433
-
Urethral strictures after radiation therapy for prostate cancer.Investig Clin Urol. 2016 Sep;57(5):309-15. doi: 10.4111/icu.2016.57.5.309. Epub 2016 Sep 7. Investig Clin Urol. 2016. PMID: 27617311 Free PMC article. Review.
-
Radiation Induced Cystitis and Proctitis - Prediction, Assessment and Management.Asian Pac J Cancer Prev. 2015;16(14):5589-94. doi: 10.7314/apjcp.2015.16.14.5589. Asian Pac J Cancer Prev. 2015. PMID: 26320421 Review.
Cited by
-
What Is the Value of Surgical Intervention for Sacral Metastases?PLoS One. 2016 Dec 19;11(12):e0168313. doi: 10.1371/journal.pone.0168313. eCollection 2016. PLoS One. 2016. PMID: 27992502 Free PMC article.
-
Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.Br J Cancer. 2014 May 13;110(10):2389-95. doi: 10.1038/bjc.2014.191. Epub 2014 Apr 10. Br J Cancer. 2014. PMID: 24722181 Free PMC article. Clinical Trial.
-
Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer.Radiat Oncol. 2013 Nov 19;8:271. doi: 10.1186/1748-717X-8-271. Radiat Oncol. 2013. PMID: 24252686 Free PMC article.
-
Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30.Qual Life Res. 1996 Apr;5(2):212-22. doi: 10.1007/BF00434743. Qual Life Res. 1996. PMID: 8998490
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
